Key result
ARBs lead outpatient antihypertensive use in Vietnam, prescribed to ~61% of patients.
Why the study?
Vietnamese studies of outpatient antihypertensive drug utilization vary across settings, populations, and reporting formats, requiring a systematic synthesis to clarify prescribing and combination-treatment patterns.
Systematic Review
Yes
This systematic review of 32 Vietnamese studies from 2021 to 2025 demonstrates that ARBs, beta-blockers, and CCBs are the most frequently prescribed outpatient antihypertensive classes and that two- to three-drug combinations predominate, while highlighting a critical need for standardized reporting of single-pill combinations and drug regimens.
Answers are grounded in this paper and cite their sources.
Informs Vietnamese hypertension prescribing patterns; extends real-world data on ARB/BB/CCB preferences and combinations in Asia.
Background: Vietnamese studies of outpatient antihypertensive drug utilization differ in settings, populations, and reporting formats. A systematic synthesis can clarify prescribing and combination-treatment patterns. Objectives: To synthesize outpatient antihypertensive drug utilization reported in Vietnam during 2021–2025 and describe general hypertension populations separately from special populations. Methods: This systematic review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020. PubMed, Google Scholar, Vietnamese medical and pharmaceutical journals were searched. Methodological quality was appraised using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Studies Reporting Prevalence Data. Study-level proportions were summarized with medians, interquartile ranges (IQRs), and ranges. Results: Thirty-two independent studies were included: 21 in general outpatient hypertension populations and 11 in special populations. In general populations, median study-level use was 61.3% for angiotensin II receptor blockers (ARBs), 52.3% for beta-blockers (BBs), 50.5% for calcium channel blockers (CCBs), 25.2% for angiotensin-converting enzyme inhibitors (ACE inhibitors), and 23.5% for diuretics. Median monotherapy was 22.1%; two-drug and three-drug regimens were 37.0% and 25.5%, respectively. Special populations showed more frequent CCB use and multidrug therapy. JBI appraisal indicated generally adequate information for descriptive synthesis. Conclusions: ARBs, CCBs, and BBs are frequently used in Vietnamese outpatient hypertension care, and two- to three-drug regimens are common, particularly in patients with comorbidities. Standardized reporting of drug classes, regimens, and single-pill combinations would improve comparability across settings.
No takes yet. Share an insight, caveat, or question.
Hoàng et al. (2026) conducted a systematic review in Hypertension. Antihypertensive drug utilization (ARBs, BBs, CCBs, ACEis, diuretics) vs. Special hypertension populations (chronic kidney disease/dialysis, type 2 diabetes, elderly) was evaluated on Study-level median utilization proportion of angiotensin II receptor blockers (ARBs) in general outpatient hypertension populations. Angiotensin II receptor blockers, beta-blockers, and calcium channel blockers were the most commonly used antihypertensive classes among Vietnamese outpatients.
Synapse has enriched 10 related papers. Consider them for comparative context: